173 related articles for article (PubMed ID: 10503090)
1. The impact of special programs for kidney transplantation of highly sensitized patients in Eurotransplant.
Doxiadis II; De Meester J; Smits JM; Witvliet M; de Lange P; Persijn GG; Claas FH
Clin Transpl; 1998; ():115-20. PubMed ID: 10503090
[TBL] [Abstract][Full Text] [Related]
2. Renal transplantation of highly sensitised patients via prioritised renal allocation programs. Shorter waiting time and above-average graft survival.
De Meester J; Doxiadis II; Persijn GG; Claas FH
Nephron; 2002 Sep; 92(1):111-9. PubMed ID: 12187093
[TBL] [Abstract][Full Text] [Related]
3. Acceptable HLA mismatches for highly immunized patients.
Claas FH; De Meester J; Witvliet MD; Smits JM; Persijn GG; Doxiadis II
Rev Immunogenet; 1999; 1(3):351-8. PubMed ID: 11256426
[TBL] [Abstract][Full Text] [Related]
4. Organ shortage and a long waiting list allow local kidney allocation to insure both short ischemia time and good HLA-A, B, DR matching.
Mosca F; Bertoni E; Tosi P; Bandini S; Rosati A; Pradella F; Mattiuz P; Taddei G; Nicita G; Rindi P
Transplant Proc; 1995 Oct; 27(5):2695-6. PubMed ID: 7482878
[No Abstract] [Full Text] [Related]
5. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients.
Duquesnoy RJ; Howe J; Takemoto S
Transplantation; 2003 Mar; 75(6):889-97. PubMed ID: 12660520
[TBL] [Abstract][Full Text] [Related]
6. Kidney transplant policy on HLA matching and waiting list.
Adorno D; Papola F; Valeri M; Piazza A; Torlone N; Monaco PI; Provenzani L; Celeste MG; Casciani CU
Transplant Proc; 1991 Oct; 23(5):2680. PubMed ID: 1926534
[No Abstract] [Full Text] [Related]
7. Allocation of organs, particularly kidneys, within Eurotransplant.
Persijn GG
Hum Immunol; 2006 Jun; 67(6):419-23. PubMed ID: 16728263
[TBL] [Abstract][Full Text] [Related]
8. SEOPF high-grade match algorithm: the effect of HLA matching with ROP trays in transplanting highly sensitized patients. Southern Organ Procurement Foundation.
Tardif GN; McCalmon RT
Clin Transplant; 1996 Dec; 10(6 Pt 2):594-7. PubMed ID: 8996748
[TBL] [Abstract][Full Text] [Related]
9. Is cyclosporine a match for tissue typing centers? Role of the zero HLA-A, B, and DR mismatch effect.
Cicciarelli J; Terasaki PI; Cecka M; Mickey MR
Transplant Proc; 1987 Feb; 19(1 Pt 1):647-9. PubMed ID: 3274831
[No Abstract] [Full Text] [Related]
10. Persistently low transplantation rate of ABO blood type O and highly sensitised patients despite alternative transplantation programs.
Roodnat JI; van de Wetering J; Claas FH; Ijzermans J; Weimar W
Transpl Int; 2012 Sep; 25(9):987-93. PubMed ID: 22775425
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of highly sensitized patients on the basis of acceptable HLA-A and B mismatches.
Claas FH; de Waal LP; Beelen J; Reekers P; Berg-Loonen PV; de Gast E; D'Amaro J; Persijn GG; Zantvoort F; van Rood JJ
Clin Transpl; 1989; ():185-90. PubMed ID: 2487564
[TBL] [Abstract][Full Text] [Related]
12. HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates.
Duquesnoy RJ; Witvliet M; Doxiadis II; de Fijter H; Claas FH
Transpl Int; 2004 Jan; 17(1):22-30. PubMed ID: 12955350
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of highly sensitized patients via the acceptable mismatch program or desensitization? We need both.
Doxiadis II; Claas FH
Curr Opin Organ Transplant; 2009 Aug; 14(4):410-3. PubMed ID: 19417658
[TBL] [Abstract][Full Text] [Related]
14. Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibility.
Doxiadis II; de Fijter JW; Mallat MJ; Haasnoot GW; Ringers J; Persijn GG; Claas FH
Transplantation; 2007 May; 83(9):1207-13. PubMed ID: 17496537
[TBL] [Abstract][Full Text] [Related]
15. Enhanced kidney allocation to highly sensitized patients by the acceptable mismatch program.
Claas FH; Rahmel A; Doxiadis II
Transplantation; 2009 Aug; 88(4):447-52. PubMed ID: 19696624
[No Abstract] [Full Text] [Related]
16. Regional vs. national renal sharing organizations: pros and cons.
Bertoni E; Carmellini M; Bandini S; Tosi P; Zanazzi M; Rosati A; Pradella F; Fossombroni V; Rindi P; Rizzo G; Mattiuz P; Mosca F; Salvadori M
Clin Transplant; 1997 Jun; 11(3):214-6. PubMed ID: 9193845
[TBL] [Abstract][Full Text] [Related]
17. The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: short waiting time and excellent graft outcome.
Claas FH; Witvliet MD; Duquesnoy RJ; Persijn GG; Doxiadis II
Transplantation; 2004 Jul; 78(2):190-3. PubMed ID: 15280676
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of the frequency of anti-HLA hyperimmunization in patients with kidney transplantation].
Pongratz G; Goumaz C; Gore SM; Bradley BA; Jeannet M
Schweiz Med Wochenschr; 1990 Sep; 120(37):1335-8. PubMed ID: 2218455
[TBL] [Abstract][Full Text] [Related]
19. Impact of HLA matching on the outcome of simultaneous pancreas-kidney transplantation.
Berney T; Malaise J; Morel P; Toso C; Demuylder-Mischler S; Majno P; Bühler LH; Mentha G;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii48-53, ii62. PubMed ID: 15814550
[TBL] [Abstract][Full Text] [Related]
20. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients.
Meier-Kriesche HU; Scornik JC; Susskind B; Rehman S; Schold JD
Transplantation; 2009 Jul; 88(1):23-9. PubMed ID: 19584676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
